Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 13 studies | 33% ± 14% | |
peripheral blood | 10 studies | 21% ± 6% | |
intestine | 7 studies | 27% ± 10% | |
liver | 6 studies | 29% ± 20% | |
kidney | 5 studies | 19% ± 4% | |
breast | 4 studies | 20% ± 3% | |
pancreas | 3 studies | 37% ± 9% | |
placenta | 3 studies | 31% ± 7% | |
uterus | 3 studies | 31% ± 22% | |
brain | 3 studies | 18% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 1628.42 | 226 / 226 | 100% | 213.79 | 406 / 406 |
ovary | 100% | 603.45 | 180 / 180 | 100% | 181.38 | 430 / 430 |
uterus | 100% | 1016.23 | 170 / 170 | 100% | 254.60 | 459 / 459 |
skin | 100% | 1689.22 | 1808 / 1809 | 100% | 169.62 | 472 / 472 |
esophagus | 100% | 1153.61 | 1444 / 1445 | 100% | 134.36 | 183 / 183 |
lung | 100% | 2419.49 | 577 / 578 | 100% | 224.24 | 1153 / 1155 |
intestine | 100% | 1286.51 | 966 / 966 | 100% | 198.45 | 525 / 527 |
thymus | 100% | 1019.29 | 651 / 653 | 100% | 182.20 | 604 / 605 |
stomach | 100% | 927.06 | 359 / 359 | 99% | 168.07 | 284 / 286 |
breast | 100% | 1001.47 | 458 / 459 | 99% | 181.07 | 1111 / 1118 |
adrenal gland | 100% | 1524.18 | 258 / 258 | 99% | 120.44 | 228 / 230 |
bladder | 100% | 1004.19 | 21 / 21 | 99% | 226.77 | 499 / 504 |
prostate | 100% | 1017.34 | 244 / 245 | 99% | 154.83 | 498 / 502 |
brain | 99% | 749.45 | 2604 / 2642 | 100% | 107.67 | 705 / 705 |
kidney | 100% | 1187.79 | 89 / 89 | 99% | 94.55 | 888 / 901 |
pancreas | 96% | 531.49 | 315 / 328 | 99% | 141.98 | 177 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 141.28 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 296.61 | 29 / 29 |
muscle | 100% | 4078.25 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1007.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 207.97 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 243.53 | 1 / 1 |
adipose | 100% | 909.40 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 796.34 | 1324 / 1335 | 0% | 0 | 0 / 0 |
heart | 97% | 1062.04 | 831 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 74% | 840.56 | 687 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032543 | Biological process | mitochondrial translation |
GO_0005762 | Cellular component | mitochondrial large ribosomal subunit |
GO_0005739 | Cellular component | mitochondrion |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0003735 | Molecular function | structural constituent of ribosome |
GO_0003723 | Molecular function | RNA binding |
Gene name | MRPL14 |
Protein name | Large ribosomal subunit protein uL14m (39S ribosomal protein L14, mitochondrial) (L14mt) (MRP-L14) (39S ribosomal protein L32, mitochondrial) (L32mt) (MRP-L32) |
Synonyms | RPML32 MRPL32 |
Description | FUNCTION: Forms part of 2 intersubunit bridges in the assembled ribosome. Upon binding to MALSU1 intersubunit bridge formation is blocked, preventing ribosome formation and repressing translation (Probable). . |
Accessions | ENST00000372014.5 Q6P1L8 |